MOLOGEN AG strengthened liquidity by successful capital increase

MOLOGEN AG (ISIN DE0006637200) has successfully placed altogether 600,000 shares with exclusion of pre-emptive rights with an institutional investor. The capital stock of the company has increased by about 9 % to 7,372,331 EUR. The capital increase has been recorded at the register of companies.

The shares were issued at a price close to the share price at the stock exchange. This cash inflow improved the company's position in negotiations with international partners from the pharmaceutical industry. Moreover, MOLOGEN will use the additional capital to force research activities for its own product development.

About MOLOGEN

MOLOGEN uses its proprietary DNA technologies to create and develop treatments for high-unmet-need illnesses. The main focuses are the unique and patented MIDGE and dSLIM technologies. Based on these platforms, MOLOGEN is developing DNA-based vaccines and therapeutics to prevent or cure a wide range of diseases.

Going public in 1998, MOLOGEN was one of the first German biotechnology companies to be floated on the stock exchange. The MOLOGEN shares are traded on the Geregelter Markt in Frankfurt.

Disclaimer concerning prognoses

Certain statements in this communication contain formulations or terms referring to the future or future developments, as well as negations of such formulations or terms, or similar terminology. These are described as forward-looking statements. In addition, all information in this communication regarding planned or future results of business segments, financial classification numbers, developments of the financial situation, or other financial or statistical data contains such forward-looking statements. The company cautions prospective investors not to rely on such forward-looking statements as certain prognoses of actual future events and developments. The company is neither responsible nor liable for these forward-looking statements. It is not responsible for updating such information, which only represents the state of affairs on the day of publication.

back to the overview